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Abstract
Background: Active and passive smoking are considered as risk factors for asthma development.
The mechanisms involved are currently unexplained.
Objective: The aim of this study was to determine if cigarette smoke exposure could facilitate
primary allergic sensitization.
Methods: BALB/c mice were exposed to aerosolized ovalbumin (OVA) combined with air or
tobacco smoke (4 exposures/day) daily for three weeks. Serology, lung cytopathology, cytokine
profiles in bronchoalveolar lavage fluid (BALF) and on mediastinal lymph node cultures as well as
lung function tests were performed after the last exposure. The natural history and the immune
memory of allergic sensitization were studied with in vivo recall experiments.
Results: Exposure to OVA induced a small increase in OVA-specific serum IgE as compared with
exposure to PBS (P < 0.05), while no inflammatory reaction was observed in the airways. Exposure
to cigarette smoke did not induce IgE, but was characterized by a small but significant neutrophilic
inflammatory reaction. Combining OVA with cigarette smoke not only induced a significant
increase in OVA-specific IgE but also a distinct eosinophil and goblet cell enriched airway
inflammation albeit that airway hyperresponsiveness was not evidenced. FACS analysis showed in
these mice increases in dendritic cells (DC) and CD4+ T-lymphocytes along with a marked increase
in IL-5 measured in the supernatant of lymph node cell cultures. Immune memory experiments
evidenced the transient nature of these phenomena.
Conclusion: In this study we show that mainstream cigarette smoke temporary disrupts the
normal lung homeostatic tolerance to innocuous inhaled allergens, thereby inducing primary
allergic sensitization. This is characterized not only by the development of persistent IgE, but also
by the emergence of an eosinophil rich pulmonary inflammatory reaction.
Background
Cigarette smoke can trigger acute symptoms in patients
with asthma, and exposure to cigarette smoke is strongly
correlated with asthma severity [1-3]. Animal models sup-
port these findings [4,5]. Recent evidence suggests that
active smoking is a risk factor for the onset of adult asthma
[6], but whether there is a causal relationship remains a
matter of debate.
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of the immunopathology underlying asthma, the major-
ity of them are based on artificial triggers to induce airway
disease. It is well documented that the normal immune
response to inhaled harmless allergens, both in mice and
men, is tolerance [7,8]. Tolerance is a phenomenon that is
mediated by active immune mechanisms [9]. To create a
model of allergen induced airway inflammation, the nor-
mal tolerance thus has to be overcome. Mostly, an adju-
vant such as aluminium hydroxide is therefore applied
[10]. However, the clinical relevance of this approach is
limited.
The question thus arises whether environmental noxious
agents such as cigarette smoke could be one of the mech-
anisms responsible for the suppression of the tolerogenic
status in asthma. Very few experimental data are available
on this issue. One study in rats suggested that environ-
mental tobacco smoke (ETS) could augment IgE
responses to harmless allergens [11], while one other in
mice showed that particles from sidestream cigarette
smoke not only increased IgE, but also induced airway
eosinophilia upon restimulation with allergen later on
[12]. In contrast, Bowles et al. [13] indicated that ETS
exposure accompanied by nose-only allergen exposure
failed to overcome aerosol tolerance in three different
mouse strains.
The objective of this study was therefore to determine
whether mainstream cigarette smoke could inhibit inhala-
tional tolerance and thus facilitate sensitization to a harm-
less antigen. We developed and characterized a new
model in which mice were simultaneously exposed to aer-
osolized OVA and mainstream smoke, without any prior
(aluminium-assisted) immunization.
Methods
Animals
Male inbred BALB/c mice of about eight weeks old were
obtained from Harlan CBP (Zeist, the Netherlands). Food
and water were provided ad libitum and mice were kept in
a 12 h-light, 12 h-dark cycle. The local Ethical Committee
(ECP Ghent University) approved the in vivo manipula-
tions used in this study.
In vivo tobacco smoke and allergen exposure
Mainstream cigarette smoke exposures were performed in
a plexiglas chamber 17 cm × 28 cm × 14 cm with an inlet
for pressurized air (1.25 L/min), connected to a smoking
machine designed by Shapiro (St. Louis, MO) [14].
Groups of 8 mice were exposed to mainstream smoke of 5
Kentucky Reference cigarettes (2R4F without filter)(Uni-
versity of Kentucky, Lexington, KY, USA) for 7 min, 4
times a day. Carboxyhemoglobin-levels in blood were
8.29 ± 1.4% in smoke-exposed vs. 1.02 ± 0.22% in air-
exposed mice (n = 7). During air or smoke exposure, con-
current challenges with phosphate buffered saline (PBS)
or OVA (Grade III; Sigma Chemical Co., Poole, UK)(1%
in PBS) were performed using an ultrasonic aerosol gener-
ator for 7 min, 4 times a day (Sirius Nova, Heyer Medizin-
technologie, Bad Ems, Germany).
Experimental protocols
1) Acute exposure model
Groups of 8 mice received exposures as detailed above to
either PBS and air, OVA and air, PBS and smoke or OVA
and smoke. The exposures took place 5 days a week for
three consecutive weeks. 24 hours after the last exposure,
the mice were sacrified, samples were taken and lymph
node cells were cultured.
Table 1: Total cell number, number of eosinophils, lymphocytes, macrophages and neutrophils in bronchoalveolar lavage fluid of mice 
exposed to phosphate buffered saline (PBS) or ovalbumin (OVA) combined with air or cigarette smoke (SM) for three weeks. Three 
weeks after the last exposure, all mice were rechallenged in vivo to 1% OVA aerosol on 3 consecutive days. (n = 8 per group. Values 
are reported as mean ± SEM. No significant differences were observed.)
PBS/air PBS/smoke OVA/air OVA/smoke
Total cell number (*103) 445.7 ± 41.0 475.0 ± 49.8 525.0 ± 25.5 470.0 ± 35.4
Eosinophils 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 1065.0 ± 968.8
Lymphocytes 367.7 ± 186.6 168.0 ± 168.0 2507.5 ± 825.1 5448.0 ± 2932.2
Macrophages (*103) 444.3 ± 41.0 473.5 ± 49.8 520.3 ± 25.1 460.5 ± 36.0
Neutrophils 964.0 ± 432.1 1322.7 ± 281.6 2113.5 ± 848.0 2622.5 ± 1597.9
Serum ovalbumin-specific IgE and IgG1 (U/ml) in mice exposed to phosphate buffered saline (PBS) or ovalbumin (OVA) combined wi h air o  cigarette smoke (SM) for three weekFig r  1
Serum ovalbumin-specific IgE and IgG1 (U/ml) in mice 
exposed to phosphate buffered saline (PBS) or ovalbumin 
(OVA) combined with air or cigarette smoke (SM) for three 
weeks. (n = 8 per group. Values are reported as mean ± 
SEM) (*P < 0.05; **P < 0.001).
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To test the immune memory responses 3 weeks after the
last exposure, mice were re-exposed to 1% OVA aerosol
for 30 min on 3 consecutive days. 24 hours after the last
recall, the mice were sacrified for analysis.
Bronchoalveolar lavage
Bronchoalveolar lavage (BAL) was performed via 3 intrat-
racheal instillations with 0.3 ml Hank's balanced salt
solution (HBSS; Pasteur, Brussels, Belgium) + 1% Bovine
Serum Albumin, followed by 3 instillations with 1 ml of
HBSS to collect cells for cytospin analysis. After staining
with May-Grünwald-Giemsa, total and differential cell
counts were done using standard morphologic criteria.
BAL cells and cells from lung digest were analyzed by Flu-
orescence Activated Cell Sorter (FACS).
Measurement of total and ovalbumin-specific IgE and 
IgG1
Blood was collected by cardiac puncture for measurement
of total and OVA-specific IgE and IgG1 with ELISA as
described before [5].
Mediastinal lymph node cell culture
Paratracheal and parathymic intrathoracic lymph nodes
were collected into sterile tubes containing cold (4°C) tis-
sue culture medium (TCM) and digested to obtain a single
cell suspension. These cells were then cultured in TCM in
a flat-bottom, 96-well plate (Becton Dickinson (BD), CA,
USA) alone or with OVA (0, 10 or 100 µg/ml), at a density
of 8*105 cells per well. After 5 days, supernatants were
harvested and frozen for cytokine measurements.
Immunofluorescent labeling and flow cytometry
Lung digest was performed as described before [15] and
cells were labeled for flow cytometry. In brief, cells of lav-
age fluid and the right lung were pre-incubated with Fc-
receptor blocking antibody (anti-CD16/CD 32, clone
2.4G2) to reduce non-specific binding. Dendritic cells
were identified as described before [16,17]. For identifica-
tion of CD11c+ dendritic cells, biotinylated anti-CD11c
(N418) was used, and for MHCII, anti-IA/IE (M5/114)
was used.
Monoclonal antibodies used to identify lymphocytes
were: biotinylated anti-CD3 (145-2C11), FITC-conju-
gated anti-CD4 (GK1.5), FITC-conjugated anti-CD8 (53–
6.7), and PE-conjugated anti-CD69 (H1.2F3). Bioti-
nylated antibodies were revealed using streptavidin-APC
(Sav-APC). Before analysis, cells were incubated with 7-
amino-actinomycin (7AAD or Viaprobe) 10 min at room
temperature for dead cell exclusion. All reagents were
obtained from BD Pharmingen (Erembodegem, Bel-
gium). Flow cytometry data were acquired on a FACSVan-
tage SE flow cytometer running CELLQuest 3.0™ (BD).
FlowJo software (Treestar, CA, USA) was used for data
analysis.
Cytokine and chemokine measurements
On supernatant of lavage fluid, IL-13, tumor necrosis fac-
tor-α (TNF-α), granulocyte-macrophage colony-stimulat-
ing factor (GM-CSF), thymus- and activation regulated
cytokine (TARC/CCL17) and IFN-γ were measured with
ELISA (R & D, Abingdon, UK). Cytometric Bead Array
(CBA, BD) was used to detect the cytokines interleukin
(IL)-4, IL-5, IL-10 and IL-13 in supernatants of lymph
node cell cultures.
Histologic analysis
Formalin-fixed, paraffin-embedded lung lobes were cut
into 3 µm sections and stained with Congo red or periodic
acid-Schiff (PAS) to highlight eosinophils and goblet
cells, respectively. Quantification of inflammation was
performed in a blinded fashion using a Zeiss KS400 Image
Analyzer (Oberkochen, Germany) running a custom-
made morphometry program. For each mouse, digital
images of five bronchi were acquired. Quantitative meas-
urements were performed in all airways with a perimeter
of basement membrane (Pbm) between 800 and 2000
µm and cut in reasonable cross sections (ratio of maximal
to minimal internal diameter smaller than 1.8). Morpho-
metrical parameters, like the perimeter of the basement
membrane (Pbm) were marked manually on the digital
representation of the airway, as described before [18,19].
Assessment of airway responsiveness
Twenty-four hours after the final exposure, lung resistance
at baseline and that induced by increasing doses of carba-
Number of eosinophils, lymphocytes and dendritic cells in bronchoalveolar lavage f uid of mic  expos d to phosphate uffered saline (PBS) or ovalbu in (OVA) combined with air o  cigarette smoke (SM) for three w eksFigu  2
Number of eosinophils, lymphocytes and dendritic cells in 
bronchoalveolar lavage fluid of mice exposed to phosphate 
buffered saline (PBS) or ovalbumin (OVA) combined with air 
or cigarette smoke (SM) for three weeks. (n = 8 per group. 
Values are reported as mean ± SEM) (*P < 0.01 vs. OVA/air-
exposed group; §P < 0.01 vs. PBS/smoke-exposed group).
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Respiratory Research 2006, 7:49 http://respiratory-research.com/content/7/1/49chol, was evaluated with a computerized pulmonary
mechanics analyzer (Mumed lung function recording sys-
tem, version 5.0, 1999, Mumed systems Ltd., London,
U.K.) as described before [5]. Carbachol-induced bron-
choconstriction was measured as the percentage increase
in lung resistance (RL), comparing the peak of the reac-
tion with baseline RL.
Statistical analysis
Each group contained 8 mice. Reported values were
expressed as mean ± standard error of the mean (SEM). P-
values of less than 0.05 were regarded as significant. For
the statistical analysis, SPSS 11.0 was used (SPSS Inc. Chi-
cago, IL, USA). All outcome variables were compared
using non-parametrical tests (Kruskal-Wallis; Mann-Whit-
ney U-test with Bonferroni's corrections).
Results
Total and OVA-specific IgE and IgG1 in serum
Total IgE in serum was not increased in mice exposed to
either OVA or cigarette smoke as compared to PBS/air-
exposed mice (0.07 ± 0.02 µg/ml). In mice exposed to
both OVA and cigarette smoke, a small increase in total
IgE (0.14 ± 0.01 µg/ml) was observed vs. smoke-exposed
(0.07 ± 0.01 µg/ml; P < 0.05), but not vs. OVA-exposed
mice (0.10 ± 0.02 µg/ml). OVA-specific IgE and IgG1 was
significantly higher in mice exposed to OVA vs. PBS.
Simultaneous exposure to OVA and cigarette smoke
caused a further increase in the OVA-specific IgE (Figure
1A) and IgG1 (Figure 1B) (P < 0.05).
Bronchoalveolar lavage fluid
Neither OVA nor smoke exposure during three weeks
caused a significant change in total BAL cell number, as
compared to PBS- and air-exposed animals (542.5 × 103 ±
64.5 × 103 and 805.0 × 103 ± 122.1 × 103 vs. 607.5 × 103 ±
74.2 × 103 respectively; P > 0.05). However, in mice simul-
taneously exposed to OVA and cigarette smoke, an
increased total cell number was seen in the BAL fluid
(1090.0 × 103 ± 92.0 × 103; P < 0.001 vs. OVA/air-exposed
mice). Smoke exposure as such increased the number of
neutrophils in BAL fluid (3.8 × 103 ± 0.5 × 103 vs. 0.6 × 103
± 0.3 × 103 in air-exposed mice; P < 0.01)(12.8 × 103 ± 5.1
× 103 in OVA- and smoke-exposed mice vs. 0.9 × 103 ± 0.4
× 103 in OVA- and air-exposed mice; P < 0.05). Exposure
to either OVA or cigarette smoke alone did not induce
eosinophil, lymphocyte and DC influx in BALF as com-
pared to PBS exposure (Figure 2). The combination of cig-
arette smoke and OVA caused a significant increase in the
number of these three cell types recovered from BAL (P <
0.01 compared to all treatments) (Figure 2).
OVA or smoke exposure as such did not affect the number
of macrophages in BAL fluid, but mice exposed simultane-
ously to OVA and smoke showed higher BAL macrophage
numbers compared to PBS/air-exposed mice (1000.3 ×
103 ± 91.6 × 103 vs. 604.6 × 103 ± 74.3 × 103; P < 0.01) and
to OVA/air-exposed mice (539.4 × 103 ± 64.7 × 103; P <
0.01), but not compared to PBS/smoke-exposed mice
(795.0 × 103 ± 120.5 × 103).
Cellular changes in lung tissue
In mice exposed to both OVA and cigarette smoke, the
number of dendritic cells, activated CD4+ and activated
Eosinophils per mm2 in the airway wall of mice exposed to phosphate buffered saline (PBS) or ovalbu n (OVA) com-bined wi h air o  cigare te smoke (SM) for thre  weeksFigure 4
Eosinophils per mm2 in the airway wall of mice exposed to 
phosphate buffered saline (PBS) or ovalbumin (OVA) com-
bined with air or cigarette smoke (SM) for three weeks. (n = 
8 per group. Values are reported as mean ± SEM) (*P < 0.01; 
**P < 0.001).
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Number of dendritic cells, CD4+ T-lymphocytes and CD8+ 
T-lymphocytes in lung tissue of mice exposed to phosphate 
buffered saline (PBS) or ovalbumin (OVA) combined with air 
or cigarette smoke (SM) for three weeks. (n = 8 per group. 
Values are reported as mean ± SEM) (*P < 0.01 vs. OVA/air-
exposed group; §P < 0.01 vs. PBS/smoke-exposed group).
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Respiratory Research 2006, 7:49 http://respiratory-research.com/content/7/1/49CD8+ T-lymphocytes in lung tissue were more than dou-
bled compared to all other groups (Figure 3). Histologic
analysis showed that mice exposed to OVA and cigarette
smoke developed peribronchial infiltrates that contained
increased numbers of eosinophils as compared to all
other groups (Figure 4; Figure 6A and 6B). On PAS-stained
tissue sections, neither OVA nor smoke exposure as such
induced goblet cell hyperplasia in BALB/c mice. In mice
that were simultaneously exposed to both stimuli, a mas-
sive goblet cell hyperplasia was observed (20.26 ± 7.7
goblet cells/µm basement membrane)(Figure 5; Figure 6C
and 6D).
Cytokine and chemokine levels in BALF supernatant
TARC/CCL17 and IFN-γ levels in BALF did not increase
significantly in the groups exposed to either OVA or ciga-
rette smoke as compared to PBS- and air-exposed mice.
However, simultaneous exposure to OVA and smoke sig-
nificantly augmented TARC and IFN-γ levels in BALF as
compared to all other groups (Figure 7). There were no
significant differences in GM-CSF (1.95 ± 0.84 vs. 1.87 ±
1.08 pg/ml) between the mice exposed to OVA and smoke
versus OVA as such. IL-13 and TNF-α were below detec-
tion limit in all groups.
Cytokine levels in supernatants of lymph node cell cultures
Since a distinct allergic inflammation was observed in
mice concurrently exposed to OVA and smoke, we inves-
tigated cytokines in the mediastinal lymph nodes. There-
fore, lymph node cell cultures were stimulated with 0, 10
or 100 µg/ml OVA, and a dose-dependent increase in IL-
4, IL-5, IL-10 and IL-13 was observed in all mice that were
at first challenged with OVA, regardless of the presence of
cigarette smoke (Figure 8). IL-5 was significantly increased
only in the mice exposed to both OVA and smoke (Figure
8).
Airway responsiveness
In the acute experiment, no significant differences were
observed between the four groups in baseline lung resist-
ance (RL = 359.35 ± 9.58 cm H2O/liter/sec = mean of
baseline resistances of the four groups). After three weeks
of OVA and/or smoke exposure, the dose-response curve
for carbachol was not significantly different from those of
naïve animals (data not shown).
In vivo recall challenge with ovalbumin
To investigate whether the adjuvant-like effects of ciga-
rette smoking were long-lasting, an in vivo rechallenge
experiment was performed. 4 groups of 8 mice were sub-
jected to the same exposures as in the acute experiment,
and after a resting period of 3 weeks, all mice were
exposed to 1% OVA aerosol for 30 min on 3 consecutive
days.
After the in vivo recall challenges, OVA-specific IgE was
higher in mice that were at first exposed to both OVA and
cigarette smoke (1.28 ± 0.4 U/ml in OVA/smoke- vs. 0.00
± 0.0 in PBS/air- and in PBS/smoke-exposed mice; P <
0.05, and vs. 0.20 ± 0.07 in OVA/air-exposed mice; P <
0.05).
The cell numbers and differential cell counts in BALF were
comparable between the four groups and compared also
with the numbers in the negative control group (PBS/air)
of the acute experiment (Table 1). No significant peri-
bronchial infiltrates of eosinophils were reported in any
of the four groups (data not shown), the inflammatory
reaction of the OVA/smoke group had disappeared com-
pletely. Only the number of goblet cells was increased in
the OVA- and smoke-exposed mice after the recall (2.62 ±
0.8 goblet cells/µm basement membrane in OVA/smoke
vs. 0.60 ± 0.3 in PBS/air; P < 0.05, vs. 0.23 ± 0.1 in PBS/
smoke; P < 0.05 and vs. 0.33 ± 0.2 in OVA/air; P < 0.05),
but this phenomenon was almost 10-fold less than after
the acute exposures.
Discussion
In this study, we provide further evidence for the hypoth-
esis suggesting that exposure to cigarette smoke can dis-
rupt the normal tolerogenic immune responses against
harmless antigens. Our data suggest that cigarette smoke
can be depicted not only as an aggravating factor for exist-
ing airway inflammation [5], but also as a facilitating and
Goblet cells in the airway wall of mice exposed to phosphate buffered saline (PBS) or ovalbumin (OVA) combined wit  airor cigarette smoke (SM) for three w eksFigu  5
Goblet cells in the airway wall of mice exposed to phosphate 
buffered saline (PBS) or ovalbumin (OVA) combined with air 
or cigarette smoke (SM) for three weeks. Definition of 
abbreviations: Pbm = perimeter of basement membrane (n = 
8 per group. Values are reported as mean ± SEM) (*P < 0.01 
versus OVA/air-exposed group; §P < 0.001 vs. PBS/smoke-
exposed group).
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Respiratory Research 2006, 7:49 http://respiratory-research.com/content/7/1/49evitable factor in the development of allergic airway dis-
ease.
Repeated exposure to aerosolized harmless inert antigens
such as OVA or pollen allergens without a prior systemic,
adjuvant aided sensitization does in naïve mice not lead
to pulmonary disease, although small increases in IgE
have been noted [7,12,20,21]. The current results under-
score these findings with the documentation of low serum
OVA-specific IgE values but no airway disease upon OVA
exposure. This means that, in the absence of additional
signals, endogenous tolerogenic mechanisms hold con-
trol [9].
These additional signals may vary in nature. Some aller-
gens contain intrinsic enzymatic activity (e.g. protease
activity in house dust mite extracts), which can raise
endogenous signals while other additional signals func-
tion independent of allergen (e.g. respiratory viruses).
However, they are all potentially responsible for the sup-
pression of normal tolerance [22]. In experimental mod-
els, the adjuvant aluminium hydroxide is also known to
overcome the normal inhalational tolerance against inert
proteins such as OVA or pollen allergens.
Cigarette smoking represents a real social problem with
enormous health consequences. Exposure to tobacco
smoke causes chronic obstructive pulmonary disease and
lung cancer. Furthermore, it increases the severity of
asthma but its role in asthma development is more con-
troversial. Along with mouse models of COPD and
emphysema [17], it has now become feasible to evaluate
the potential role of cigarette smoke as clinically relevant
danger signal in the natural history of asthma. Short-term
exposure to cigarette smoke (3 weeks) does in our hands
not lead to overt pulmonary disease or emphysema, the
latter being evidenced after long term exposure [17]. Nev-
ertheless, we observed a small but significant increase in
the number of neutrophils in BALF suggestive for an acute
toxic effect.
We thus combined this cigarette smoke exposure protocol
with OVA aerosols in naive animals and show that besides
a significant additive effect on the development of specific
IgE and IgG1, also active and eosinophil enriched pulmo-
nary inflammation develops. Others also used naive mice
to demonstrate that exposure to aerosolized cigarette
smoke extracts could induce an augmentation in IgE to an
otherwise innocuous antigen [12]. In the latter report,
Cytokines in BAL fluid supernatant (pg/ml) of mice exposed to phosphate buffere  saline (PBS) or ova bumin (OVA) com-bined with air or cigarette smoke (SM) for three w eksFigure 7
Cytokines in BAL fluid supernatant (pg/ml) of mice exposed 
to phosphate buffered saline (PBS) or ovalbumin (OVA) com-
bined with air or cigarette smoke (SM) for three weeks. Def-
inition of abbreviations: TARC = thymus and activation 
regulated chemokine (n = 8 per group. Values are reported 
as mean ± SEM) (*P < 0.01, & P < 0.001 vs. OVA/air-exposed 
group; §P < 0.01, #P < 0.001 vs. PBS/smoke-exposed group).
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Eosinophils and goblet cells in the airway wall of mice exposed to phosphate buffered saline (PBS) or ovalbumin (OVA) combined wi h air o  cigarette smoke (SM) for three weekFigur  6
Eosinophils and goblet cells in the airway wall of mice 
exposed to phosphate buffered saline (PBS) or ovalbumin 
(OVA) combined with air or cigarette smoke (SM) for three 
weeks. A. Congo red staining for eosinophils in OVA- and 
air-exposed mice. B. Congo red staining for eosinophils in 
simultaneously OVA- and smoke-exposed mice. The arrows 
are indicating eosinophils. C. Periodic acid-Schiff staining for 
goblet cells in OVA- and air-exposed mice. D. Periodic acid-
Schiff staining for goblet cells in simultaneously OVA- and 
smoke-exposed mice.Page 6 of 9
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Respiratory Research 2006, 7:49 http://respiratory-research.com/content/7/1/49smoke extracts were generated from sidestream smoke
and mixed with saline for delivery through a nebulizer.
This differs from our study where pure cigarette fumes are
administered directly and concomitant with allergens.
However, both studies underscore the fact that cigarette
smoke effectively can act as an adjuvant to facilitate pri-
mary allergic sensitization to inert antigens. A possible
mechanism for the induction of sensitization by main-
stream smoke is that cigarette smoke extracts improve the
antigen presentation either by adsorption of allergen,
thereby causing a more persistent allergen exposure, or by
causing structural modifications to the allergen itself.
These mechanisms have also been suggested for the adju-
vant effects observed with carbon black and diesel parti-
cles [23]. In addition, cigarette smoke particles may have
an irritative effect on the epithelial surface, causing dam-
age to the mucosae and facilitating the penetration of
allergen into the epithelial layer. A contiguous network of
dendritic cells (DC) is present underneath the respiratory
epithelium ready to take up and process antigen, and to
migrate to the draining lymph nodes for presentation to
antigen specific T-cells for triggering an active immune
response [16]. The involvement of DC in the observed
pathology is suggested by the significant increase of DC in
both BALF and lung tissue in the OVA- and smoke-
exposed mice. These DC are responsible for priming and
activation of CD4+ T-cells in bronchial lymph nodes,
which recirculate via the bloodstream towards the lungs
where we could measure them (BALF and lung tissue).
Not only increases in DC and T-cells, but also a substan-
tial amount of eosinophils and to a far lesser extent of
neutrophils was noticed only in the mice exposed to the
combination of cigarette smoke and allergen. In addition,
we found a remarkable presence of goblet cells in these
airways. In this model, we were not able to demonstrate
airway hyperresponsiveness. Although methodology of
pulmonary function assessment might be important,
another possible explanation is that the time point of test-
ing was not optimal. On the other hand, it could be that
there was simply no hyperresponsiveness, possibly
because the strength of the inflammatory reaction was
insufficient. This is plausible since the magnitude of the
inflammatory response both in terms of serum IgE and
pulmonary inflammation is much less as compared to the
inflammatory responses observed after systemic priming
(with aluminium hydroxide) and airway exposures.
At the molecular level, we found that TARC was elevated
in BALF supernatant of the mice simultaneously exposed
to allergen and cigarette smoke, whereas it remained sta-
ble after exposure to either ovalbumin or smoke alone.
Kawasaki et al. [24] reported that TARC is a pivotal chem-
okine for the development of Th2-dominated experimen-
tal allergen-induced asthma with eosinophilia, which fits
with our findings. Besides TARC, GM-CSF also mediates,
at least in part, Th2 sensitization and eosinophilic airway
inflammation [20,25]. We were unable to detect differ-
ences in BALF GM-CSF which contrasts with the findings
of Rumold et al. [12], who suggested this cytokine as well
as IL-5 as a possible explanation for eosinophilia observed
after a rechallenge with allergen. Intruigingly, the Th-1
cytokine IFN-γ was increased in BALF of OVA/smoke-
exposed mice. Although this most probably reflects the
toxic effects of cigarette smoke and parallels with the neu-
trophilic inflammatory reaction, it is to note that IFN-γ
did not abolish the eosinophil rich inflammation as could
be expected in the first instance [26]. In addition, elevated
levels of IFN-γ were reported in serum [27], BAL fluid [28]
and in sputum [29] of patients with asthma, all suggesting
that some of the pathology in asthma could partially be
IFN-γ driven.
The Th2 cytokines IL-4, IL-10 and IL-13 (not detectable in
BALF) were augmented in lymph node cell culture super-
natant in all mice that were initially exposed to ovalbu-
min. This suggests that, similar to what was already
described for OVA-specific IgE, a transitory rise in these T-
cell produced cytokines occurs at the level of the lymph
nodes, which is however not strong enough to induce pul-
monary disease. IL-5, another predominant Th2 cytokine,
was upregulated only in those mice exposed to both OVA
and cigarette smoke. This finding explains the eosi-
Cytokines IL-4, IL-5, IL-10 and IL-13 in lymph node cell cul-ture sup rnatant (pg/ml) after stimulation with OVA (0, 10 and 100 µg/ml)Figure 8
Cytokines IL-4, IL-5, IL-10 and IL-13 in lymph node cell cul-
ture supernatant (pg/ml) after stimulation with OVA (0, 10 
and 100 µg/ml). Mice were exposed to phosphate buffered 
saline (PBS) or ovalbumin (OVA) combined with air or ciga-
rette smoke (SM) for three weeks. (n = 8 per group. Values 
are reported as mean ± SEM) (* P < 0.05, ** P < 0.01,# P < 
0.001).
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Respiratory Research 2006, 7:49 http://respiratory-research.com/content/7/1/49nophilia in the BALF and lung tissue and again closes up
the hypothesis that DC stimulate allergen specific T-cells
to produce IL-5 upon exposure to allergen and cigarette
smoke.
Whether the observed breakdown of immunological
homeostasis after concomitant allergen and cigarette
smoke exposure with the ensuing pulmonary eosinophil
rich inflammation has a memory character was investi-
gated by performing in vivo recall experiments. Re-chal-
lenge of the mice with allergen alone after a resting period
of 3 weeks showed that the normal tolerogenic mecha-
nisms were restored, with a complete absence of pulmo-
nary inflammation. Several explanations are possible for
this observation: firstly, the sensitization to OVA facili-
tated by cigarette smoke was not long lasting. In this case
the OVA-specific IgE and the goblet cell hyperplasia was a
remainder of the acute inflammatory reaction. Another
possibility is that the rechallenge period was too short to
re-induce a marked airway inflammation. Further investi-
gation will have to shed a light on these findings.
In conclusion, in an acute mouse model we have shown
for the first time that mainstream cigarette smoke directly
disrupts the normal lung homeostatic tolerance to innoc-
uous allergens such as ovalbumin, thereby permitting
allergen induced sensitization and airway disease. Our
data might help to explain why active smoking is a risk
factor for the onset of asthma [6].
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